Short-Term Environmental Conditioning Enhances Tumorigenic Potential of Triple-Negative Breast Cancer Cells

被引:5
|
作者
Eckley, Samantha S. [1 ]
Buschhaus, Johanna M. [2 ,3 ,4 ]
Humphries, Brock A. [4 ]
Robison, Tanner H. [2 ,3 ,4 ]
Luker, Kathryn E. [2 ,3 ]
Luker, Gary D. [2 ,3 ,4 ,5 ]
机构
[1] Univ Michigan, Unit Lab Anim Med, Med Sch, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Dept Biomed Engn, Coll Engn, Ann Arbor, MI 48109 USA
[3] Med Sch, Ann Arbor, MI USA
[4] Univ Michigan, Dept Radiol, Ctr Mol Imaging, Med Sch, Ann Arbor, MI 48109 USA
[5] Univ Michigan, Med Sch, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA
基金
美国国家科学基金会; 美国国家卫生研究院;
关键词
Fluorescence; bioluminescence; signaling; breast cancer; PATHWAY ACTIVATION; STEM-CELLS; TUMOR; HYPOXIA; METASTASIS; ERK; FLUCTUATIONS; CHEMOTHERAPY; INHIBITION; RESISTANCE;
D O I
10.18383/j.tom.2019.00019
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Tumor microenvironments expose cancer cells to heterogeneous, dynamic environments by shifting availability of nutrients, growth factors, and metabolites. Cells integrate various inputs to generate cellular memory that determines trajectories of subsequent phenotypes. Here we report that short-term exposure of triple-negative breast cancer cells to growth factors or targeted inhibitors regulates subsequent tumor initiation. Using breast cancer cells with different driver mutations, we conditioned cells lines with various stimuli for 4 hours before implanting these cells as tumor xenografts and quantifying tumor progression by means of bioluminescence imaging. In the orthotopic model, conditioning a low number of cancer cells with fetal bovine serum led to enhancement of tumor-initiating potential, tumor volume, and liver metastases. Epidermal growth factor and the mTORC1 inhibitor ridaforolimus produced similar but relatively reduced effects on tumorigenic potential. These data show that a short-term stimulus increases tumorigenic phenotypes based on cellular memory. Conditioning regimens failed to alter proliferation or adhesion of cancer cells in vitro or kinase signaling through Akt and ERK measured by multiphoton microscopy in vivo, suggesting that other mechanisms enhanced tumorigenesis. Given the dynamic nature of the tumor environment and time-varying concentrations of small-molecule drugs, this work highlights how variable conditions in tumor environments shape tumor formation, metastasis, and response to therapy.
引用
收藏
页码:346 / 357
页数:12
相关论文
共 50 条
  • [1] β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
    Xu, Jinhua
    Prosperi, Jenifer R.
    Choudhury, Noura
    Olopade, Olufunmilayo I.
    Goss, Kathleen H.
    [J]. PLOS ONE, 2015, 10 (02):
  • [2] DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
    Ogbu, Stella C.
    Rojas, Samuel
    Weaver, John
    Musich, Phillip R.
    Zhang, Jinyu
    Yao, Zhi Q.
    Jiang, Yong
    [J]. CELLS, 2022, 11 (01)
  • [3] Triple-negative breast cancer: clinic-pathological feature and short-term outcomes
    Murphy, D.
    Joyce, D. P.
    McLaughlin, R.
    Kerin, M. J.
    [J]. BRITISH JOURNAL OF SURGERY, 2015, 102 : 40 - 40
  • [4] A home-based lifestyle intervention program reduces the tumorigenic potential of triple-negative breast cancer cells
    Baldelli, Giulia
    Natalucci, Valentina
    Marini, Carlo Ferri
    Sisti, Davide
    Annibalini, Giosue
    Saltarelli, Roberta
    Bocconcelli, Matteo
    Gentilini, Veronica
    Emili, Rita
    Rocchi, Marco Bruno Luigi
    Lucertini, Francesco
    Barbieri, Elena
    Brandi, Giorgio
    De Santi, Mauro
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [5] A home-based lifestyle intervention program reduces the tumorigenic potential of triple-negative breast cancer cells
    Giulia Baldelli
    Valentina Natalucci
    Carlo Ferri Marini
    Davide Sisti
    Giosuè Annibalini
    Roberta Saltarelli
    Matteo Bocconcelli
    Veronica Gentilini
    Rita Emili
    Marco Bruno Luigi Rocchi
    Francesco Lucertini
    Elena Barbieri
    Giorgio Brandi
    Mauro De Santi
    [J]. Scientific Reports, 14
  • [6] Triple-Negative Breast Cancer A Short Review
    Elias, Anthony D.
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (06): : 637 - 645
  • [7] Icaritin enhances the efficacy of cetuximab against triple-negative breast cancer cells
    Yin, Li
    Qi, Xiao-Wei
    Liu, Xun-Zhou
    Yang, Ze-Yu
    Cai, Rui-Li
    Cui, Hong-Juan
    Chen, Li
    Yu, Shi-Cang
    [J]. ONCOLOGY LETTERS, 2020, 19 (06) : 3950 - 3958
  • [8] Investigation of creep properties and the cytoskeletal structures of non-tumorigenic breast cells and triple-negative breast cancer cells
    Onwudiwe, Killian
    Obayemi, John
    Hu, Jingjie
    Oparah, Josephine
    Onyekanne, Chinyerem
    Nwazojie, Chukwudalu
    Aina, Toyin
    Uzonwanne, Vanessa
    Salifu, Ali
    Soboyejo, Winston
    [J]. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, 2022, 110 (05) : 1004 - 1020
  • [9] Lidocaine enhances the efficacy of palbociclib in triple-negative breast cancer
    Han, Beom Seok
    Jung, Kyung Hee
    Lee, Ji Eun
    Yoon, Young-Chan
    Ko, Soyeon
    Park, Min Seok
    Lee, Yun Ji
    Kim, Sang Eun
    Cho, Ye Jin
    Lee, Pureunchowon
    Lim, Joo Han
    Jang, Eunsoo
    Kim, Hyunzu
    Hong, Soon-Sun
    [J]. AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3083 - 3098
  • [10] Temozolomide Enhances Triple-Negative Breast Cancer Virotherapy In Vitro
    Garza-Morales, Rodolfo
    Gonzalez-Ramos, Roxana
    Chiba, Akiko
    Montes de Oca-Luna, Roberto
    McNally, Lacey R.
    McMasters, Kelly M.
    Gomez-Gutierrez, Jorge G.
    [J]. CANCERS, 2018, 10 (05)